2. Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395: 507–513.

3. Li Q., Guan X., Wu P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.

4. Wang L., Li X., Chen H., et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol 2020;51:343–348.

5. Wang X., Fang X., Cai Z., et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Wash D C). 2020;2020:1–17.

6. Yang A., Li H., Tao W., Yang X., et al. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients Aging (Albany NY). 2020 Jun 15; 12(11): 10059–10069.

7. Hoffman M., Kleine-Weber H., Schroeder S., et al.: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271‐280.e8.

8. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–423.

9. Martinez-Rojas M.A., Vega-Vega O., Bobadilla N.A. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020;318(6):F1454–F1462.

10. Li Z., Wu M., Yao J., et al. Kidney dysfunctions of COVID-19 patients: a multi-centered, retrospective, observational study. Social Science Research Network, Rochester, N.Y.

11. Hamming I., Timens W., Bulthuis M.L., et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.

12. Pan X., Xu D., Zhang H. et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensiv Care Med. 2020;46,:1114–1116.

13. Kim J.M., Chung Y.S., Jo H.J., et al. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect. 2020;11:3–7.

14. Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219–227.

15. Ronco C., Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. April 2020.

16. Naicker S., Yang C-W., Hwang S.-J., et al. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97:824–828.

17. Vaduganathan M., Vardeny O., Michel T., et al. Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653–1659.

18. Ronco C., Tetta C., Mariano F., et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27:792–801.

19. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

20. Desai T.R., Leeper N.J., Hynes K.L., Gewertz B.L. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118–123.

21. Diao B., Wang C., Wang R., et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv 2020. https://doi.org/10.1101/2020.03.04.20031120

22. Hua S., Ming Y., Cheng W., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020,

23. Kissling S., Rotman S., Gerber C., et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98:228–231.

24. Lerolle N., Nochy D., Guérot E., et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensiv Care Med 2010;36:471–478.

25. Cha R-H., Joh J-S., Jeong I., et al. Renal complications and their prognosis in Korean patients with middle East respiratory syndrome-coronavirus from the central MERS-CoV designated Hospital. J Korean Med Sci. 2015;30:1807–1814.

26. Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. April 2020.

27. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

28. Case J., Khan S., Khalid R., et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013;2013:479730.

29. Chawla L.S., Eggers P.W., Star R.A., et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58–66.

30. Murugan R., Kellum J.A. Acute kidney injury: what’s the prognosis? Nat Rev Nephrol. 2011;7:209–217.

31. Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97: 829–838.

32. Darmon M., Clec’h C., Adrie C., et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9:1347–1353.

33. Wölfel R., Corman V.M., Guggemos W., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469.

34. Lo I., Lio C., Cheong H., Lei C., et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau Int J Biol Sci. 2020;16(10):1698–1707.

35. Wang W., Xu Y., Gao R., et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens JAMA. 2020;323(18):1843–1844.

36. Chan V., Chiu P., Yee C., et al. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions World J Urol. 2020;27:1–12.

37. Kima J., Kima H., Leea J., Joa H., et al. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea Osong Public Health and Research Perspectives. 2020;11(3):112–117.

38. Sun J., Li H., Zhuang Z., Chen Z. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Journal Emerging Microbes & Infections. 2020;9:991–993.

39. Gaudry S., Hajage D., Schortgen F., et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122–133.

40. Wu S., Liang X., Geng J., et al. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report. World J. Clin. Cases. 2019;7(24):4377–4383.

41. Izzedine H., Jhaveri K.D., Perazella M.A. COVID-19 therapeutic options for patients with kidney disease. Kidney Int. 2020; 97(6):1297–129.

42. Moore P.K., Hsu R.K., Liu K.D. Management of Acute Kidney Injury: Core Curriculum 2018. Am J Kidney Dis. 2018.;72(I.1):136–148.